EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The impact of prolonged walking on fasting plasma glucose in type 2 diabetes: A randomised controlled crossover study

Anxious J Niwaha iD, Beverley M Shields, Lauren R Rodgers, Andrew T Hattersley, Robert C Andrews, Moffat J Nyirenda, Angus G Jones iD

Diabetic Medicine · 2025

DOI: 10.1111/dme.15468 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetic Medicine, 2025. Verfasst von Anxious J Niwaha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter Medical School, Exeter, UK. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Blood Glucose, Walking, Fasting. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research (NIHR), NIHR Exeter Clinical Research Facility.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

In many low‐income countries, fasting glucose is the primary measure for monitoring glycaemic control. Many patients in these countries walk long distances to the clinic, but the impact of walking on fasting glucose in type 2 diabetes is unknown. We aimed to determine the impact of walking on fasting glucose in people with type 2 diabetes.

Methods

In a randomised crossover trial, the change in glucose from baseline in the fasting state was compared between walking on a treadmill at a predetermined speed of 4.5 km/h for 1 h and not walking (resting) in people with type 2 diabetes.

Results

In all, 45 participants were enrolled and all completed both visits; 21/45 (46.7%) were women, and the median age was 51. Glucose during and after walking was similar to glucose while at rest; the glucose difference (walking minus rest) was −0.15 (95% CI: −0.55, 0.26) and −0.10 (95% CI: −0.50, 0.31) mmol/L at 1 and 2 h, respectively, p > 0.4 for both.

Conclusions

Fasting plasma glucose is not meaningfully affected by prolonged walking in participants with type 2 diabetes; therefore, the reliability of fasting glucose for monitoring glycaemic burden is unlikely to be altered in patients who walk to the clinic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Blood GlucoseWalkingFastingHumansFemaleCross-Over StudiesMaleMiddle AgedAdultAgedExercise Test

Stichwörter der Autor:innen

exercisefasting glucoserandomised crossover trialtype 2 diabetes

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter Medical School, Exeter, UK.
  • Medical Research Council/Uganda Virus Research Institute and LSHTM Uganda Research Unit, Entebbe, Uganda.
  • Institute of Health Research, College of Medicine and Health, University of Exeter, Exeter, UK.
  • Department of Non-communicable Diseases Epidemiology, London School of Hygiene and Tropical Medicine (LSHTM), London, UK.

ORCID-Profile: Anxious J Niwaha, Angus G Jones

Förderung

  • National Institute for Health and Care Research (NIHR)
  • NIHR Exeter Clinical Research Facility

Zitieren

APA

Niwaha, A. J., Shields, B. M., Rodgers, L. R., Hattersley, A. T., Andrews, R. C., Nyirenda, M. J., & Jones, A. G. (2025). The impact of prolonged walking on fasting plasma glucose in type 2 diabetes: A randomised controlled crossover study. Diabetic Medicine. https://doi.org/10.1111/dme.15468

Vancouver

Niwaha AJ, Shields BM, Rodgers LR, Hattersley AT, Andrews RC, Nyirenda MJ, et al. The impact of prolonged walking on fasting plasma glucose in type 2 diabetes: A randomised controlled crossover study. Diabetic Medicine. 2025. doi:10.1111/dme.15468

BibTeX
@article{Niwaha2025,
  author = {Niwaha, Anxious J and Shields, Beverley M and Rodgers, Lauren R and Hattersley, Andrew T and Andrews, Robert C and Nyirenda, Moffat J and Jones, Angus G},
  title = {The impact of prolonged walking on fasting plasma glucose in type 2 diabetes: A randomised controlled crossover study},
  journal = {Diabetic Medicine},
  year = {2025},
  doi = {10.1111/dme.15468}
}
Kostenlos starten →